Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Psychiatry/Psychology | Pulmonary/Respiratory Diseases
Disease Category: Smoking Cessation
Location: United States, TN
Clinical Trial Details
Research Study Summary
Smoking Cessation Study
We are currently recruiting smokers who are really motivated to quit smoking. The purpose of the study is to evaluate the safety and effectiveness of three approved medications, Habitrol, Zyban and Chantix, in combination and compared to a placebo (no active ingredient). Requires 12 weekly visits.
Patient Inclusion Criteria:
- Participants must be 18-75 and smoke at least 10 cigarettes a day.
Patient Exclusion Criteria:
- Patients who have had an allergic reaction to a medication, have had a DUI, seizure or stroke, are not eligible to participate. In addition, there are certain medications which would exclude the patient from participating.
To Learn more
Both Male and Female
Date Last Changed:
July 18, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.